In-Depth Ferritin Testing Market Analysis: Trends, Growth Drivers, and Forecast (2025-2031)

 

Introduction
The market for ferritin testing is expanding dramatically with a rise in iron-deficiency illnesses, greater consciousness to identify illness in the early stages, and enhanced diagnostic devices. Ferritin is an important biomarker employed for measuring the body's amount of iron, and it's an important marker while diagnosing diseases like anemia, hemochromatosis, and chronic inflammatory disease.
The blog gives a complete market analysis of the ferritin testing market, its trends, drivers, restraints, and future outlook for the period 2025-2031.

Ferritin Testing Market Overview
What is Ferritin Testing?
Ferritin testing measures the amount of ferritin—a protein that stores iron in the blood—present in the body. Low ferritin is indicative of iron deficiency, while a high reading is indicative of iron overload, liver disease, or chronic inflammation.
Market Size and Growth Forecast
The Ferritin testing market size in 2021 stood at US$ 405.24 million and is projected to reach US$ 670.74 million by 2031. The market is expected to register a CAGR of 5.3% in 2023–2031.

Key Ferritin Testing Market Trends (2025-2031)
1. Increasing Incidence of Iron Disorders
• Anemia occurs in over 1.6 billion individuals, and iron deficiency is the most frequent cause.
•Increasing frequency of hemochromatosis (iron overload), which will require regular ferritin testing.
2. Advances in Diagnostic Testing
•Automated immunoassay systems enhance test speed and accuracy.
•Point-of-care testing expands, allowing rapid ferritin measurement in clinics and at home.
3. Growing Demand for Preventive Health Care
•Pregnant women, children, and athletes increasingly worry about iron deficiency risk and need to be tested.
•Preventive care services now routinely include ferritin testing as part of a routine health check-up.
4. Hospital & Diagnostic Lab Growth
• Specialist diagnostic laboratory-based testing services and hospital-based testing services are driving market growth.
• Government initiatives for early diagnosis are driving market growth.
5. Growing Use of Home Test Kits
• Everlywell and LetsGetChecked market ferritin test kits for home use, and these are becoming more readily available.
• Telemedicine trend further is driving demand for self-testing kits.

Ferritin Testing Market Growth Drivers
1. Growing Prevalence of Chronic Disorders
•Abnormal levels of ferritin are most often due to illnesses like chronic kidney disease (CKD), inflammatory conditions, and cancer, so there is high demand for the test.
2. Government and NGO Initiatives
•Government initiatives like the WHO's Global Nutrition Targets aimed at reducing rates of anemia are increasing utilization of ferritin tests.
3. Increase in Geriatric Population
• Older people have a higher susceptibility to abnormalities in iron metabolism, thus contributing to the demand for more ferritin testing.
4. Healthcare Infrastructure Growth in Emerging Markets
• India, Brazil, and China are investing in diagnostic facilities, propelling market growth.

Ferritin Testing Market  Restraints and Challenges
1. Expensive Advanced Testing Systems
• Ferritin analyzers are costly, constraining adoption in low-resource environments.
2. Low Developing Country Awareness
• Numerous patients in Southeast Asia and Africa are still undiagnosed because of limited access to testing centers.
3. Regulatory Barriers
• FDA and CE marking approvals are slow due to stringent requirements, hindering the launch of new ferritin tests products.

Competitive Landscape
Major market players for ferritin tests are:
Eurolyser Diagnostica GmbH – Eurolyser is also broadening its diagnostic platforms to include faster and more accurate testing platforms for clinical as well as veterinary purposes. Some of the recent advancements involve revising their cube and smart analyzers in an effort to optimize laboratory efficiency.
Cortez Diagnostics Inc – Cortez Diagnostics has been increasing its ELISA and rapid test kits, primarily infectious disease and autoimmune testing. Cortez Diagnostics is also developing AI-based diagnostics to enhance test speed and accuracy.
bioMérieux SA – Microbiology market leader bioMérieux introduced new automated diagnostic platforms and increased its antimicrobial resistance (AMR) solutions, solidifying its global infectious disease control commitment.
Doctorcall – This UK supplier has been expanding its corporate and private healthcare services, occupational health, and COVID-19 testing and adding remote diagnostics to digital health solutions.
Aviva Systems Biology Corporation – Aviva is further augmenting its antibody and immunoassay toolset with more cancer biomarker and neurodegenerative disease kits. Its focus remains on high-sensitivity detection for clinical and research use.
Biopanda Reagents Ltd – Best reagents awarded, Biopanda launched new PCR and quick test kits, i.e., infectious diseases such as HIV and hepatitis, for meeting worldwide diagnostic requirements

Strategic Developments
•Product Releases: Companies are launching assays that are more sensitive to ferritin.
•Alliances: Hospital-hospital diagnostics companies' partnerships for increasing access to testing.
•Mergers & Acquisitions: Diagnostic start-ups smaller in size getting acquired by industry giants to increase market penetration.

Conclusion
The ferritin test market will expand significantly between 2025 and 2031 due to increasing disease incidence, technological advancement, and increased healthcare investments. While there can be inhibitors like high costs and regulatory challenges, improvements in POC tests, AI-based diagnostic tests, and home test kits will generate opportunities.
For healthcare providers, testing companies, and investors, identifying these trends will be crucial in order to leverage the expanding ferritin testing industry.